With over 15 years of scientific and consulting experience, Rachel contributes valuable insights to Bionest and its clients. Her role spans new product planning, go-to-market strategy, and fostering innovation for pharma, biotech, and diagnostic companies. Rachel's expertise lies in oncology and diagnostics, leading Bionest's Oncology and Precision Medicine practices. As a thought leader in the field, she collaborates to provide actionable solutions for business growth. Bionest Partners, a global consulting firm, specializes in Pharma, Biotech, Medical Device, and Diagnostics, offering strategic guidance and due diligence support.